Eva Live (NASDAQ: GOAI) establishes $100M at-the-market stock program
Rhea-AI Filing Summary
Eva Live Inc. entered into an Equity Distribution Agreement with Maxim Group LLC that allows the company to sell shares of common stock with an aggregate offering price of up to $100,000,000 in an at-the-market program.
Maxim will act as sales agent, using commercially reasonable efforts to place shares, and will receive a 3.0% commission on gross proceeds, plus specified expense reimbursements. Eva Live is not required to sell any shares and the agreement can be terminated by either party on five days’ notice or upon earlier specified events. The shares are registered under an effective Form S-3 shelf registration, and net proceeds are intended for working capital and general corporate purposes.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 1.01, 9.01
2 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
ATM program size: $100,000,000 aggregate offering price
Sales agent commission: 3.0% of gross proceeds
Initial expense reimbursement cap: $30,000
+3 more
6 metrics
ATM program size
$100,000,000 aggregate offering price
Maximum common stock sales under Equity Distribution Agreement
Sales agent commission
3.0% of gross proceeds
Commission payable to Maxim Group LLC on share sales
Initial expense reimbursement cap
$30,000
Fees and expenses reimbursable to Maxim upon execution of EDA
Ongoing expense cap per Bringdown Date
$3,500
Additional reimbursable costs per Bringdown Date under EDA
Shelf registration form
Form S-3 (File No. 333-294416)
Registration statement declared effective March 24, 2026
Agreement maximum term
Twelve-month anniversary
Automatic termination upon twelve-month anniversary of the EDA
Key Terms
Equity Distribution Agreement, at the market offering, registration statement on Form S-3, prospectus supplement, +1 more
5 terms
Equity Distribution Agreement financial
"entered into an Equity Distribution Agreement, or the EDA, with Maxim Group LLC"
An equity distribution agreement is a formal plan between a company and financial institutions to sell newly issued shares of the company's stock to investors over a period of time. It helps the company raise money gradually, similar to filling a container with water in stages, rather than all at once. For investors, it provides an organized way to buy shares and can influence the stock's supply and price.
at the market offering financial
"by any method deemed to be an “at the market” offering as defined in Rule 415"
An at-the-market offering is a way a company raises cash by selling newly issued shares directly into the open market at prevailing prices, rather than all at once in a single deal. Think of it like turning a faucet on to drip shares into trading at current prices when needed; it gives the company flexibility to raise funds over time but can dilute existing shareholders and potentially affect the stock price, which investors should monitor.
registration statement on Form S-3 regulatory
"pursuant to the registration statement on Form S-3 (File No. 333-294416)"
A registration statement on Form S‑3 is a short, standardized filing a qualified public company uses to register new securities with regulators so they can be sold to investors; think of it as a pre-approved, reusable permission slip that speeds up future offerings. It matters to investors because it lets the company raise money more quickly and cheaply — which can fund growth or pay debt — but may also lead to share dilution or change in ownership, so it affects value and liquidity.
prospectus supplement regulatory
"and a related prospectus supplement filed with the SEC on April 14, 2026"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Eva Live Inc. (GOAI) announce in this 8-K filing?
Eva Live Inc. entered an Equity Distribution Agreement with Maxim Group LLC, enabling at-the-market sales of up to $100,000,000 in common stock. Maxim will act as sales agent under specified terms, commissions, and termination rights.
How large is Eva Live Inc.’s (GOAI) new at-the-market stock program?
The Equity Distribution Agreement permits Eva Live to sell common stock with an aggregate offering price of up to $100,000,000. These shares may be issued from time to time through Maxim Group LLC under an effective Form S-3 shelf registration and related prospectus supplement.
What fees will Eva Live Inc. (GOAI) pay Maxim Group under the Equity Distribution Agreement?
Eva Live will pay Maxim a 3.0% commission on aggregate gross proceeds from share sales, plus up to $30,000 for initial fees and expenses and up to $3,500 for certain expenses on each Bringdown Date defined in the agreement.
How will Eva Live Inc. (GOAI) use net proceeds from the at-the-market offering?
Eva Live intends to use the net proceeds from any sales of common stock under the Equity Distribution Agreement for working capital and general corporate purposes, as described in the related prospectus supplement filed under its Form S-3 registration.